Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Cataract Surgery Devices Market to hit US$ 11.76 Billion by 2030 | Exclusive Report by Growth Plus Reports


NEW YORK, Oct. 6, 2022 /PRNewswire/ -- According to a new market research report titled, "Cataract Surgery Devices Market by Product (Phacoemulsification Equipment, Intraocular Lens, Ophthalmic Viscoelastic Device), by Type (Equipment, Consumables), by End User (Ophthalmic Clinics, Hospitals, Research Institutes) ? Global Outlook & Forecast 2022-2030" published by Growth Plus Reports, the Cataract Surgery Devices Market is expected to grow at a CAGR of 6.80% from 2021 to reach US$ 11.76 billion by 2030.

Growth Plus Reports Logo


The development of cutting-edge surgical methods and cutting-edge equipment has improved patient outcomes. Advanced treatments have revolutionized cataract treatment outcomes, including phacoemulsification, short incision cataract surgery, laser-assisted cataract surgery, customized intraocular lenses, and bladeless incisions. Over the assessment period, such developments in the tools and methods of cataract surgery are projected to promote the growth of the global market for cataract surgery devices.

Download Free Sample Report Now @ https://growthplusreports.com/inquiry/request-sample/cataract-surgery-devices-market/7846

Excerpts from 'by Product'

The categories of phacoemulsification equipment, intraocular lenses, and ophthalmic viscoelastic devices make up the global cataract surgery devices market. The intraocular lenses (IOLs) segment dominates the product segment. The most significant advantage of IOLs is the possibility of improved vision (Intraocular lenses). The rising use of intraocular lenses (IOLs) globally is also projected to accelerate the market for devices used in cataract surgery soon.

Excerpts from 'by Type'

According to type, the global cataract surgery devices market is segmented into:

The consumables segment will continue to experience market growth during the projection period. The prevalence of eye diseases is on the rise, and medical technology breakthroughs like lasers and computer-controlled optical delivery systems are contributing to the expansion.

Excerpts from 'By Region'

The market for cataract surgical devices is divided into four geographic segments:

North America has dominated the cataract surgery market. The prevalence of cataracts in the senior population is the leading market driver propelling the growth of the market globally. Additionally, there are several investments in this North American cataract surgery market. Asia Pacific region for cataract surgery market is growing steadily. The market has enormous growth potential. Europe is another major contributor to the global cataract surgery devices market, with considerable investments in cataract surgery. Furthermore, a large patient population suffering from chronic diseases such as diabetes resulting in cataracts is boosting the global market growth.

Inquiry Before Buying: https://growthplusreports.com/inquiry/before-buying/cataract-surgery-devices-market/7846

Excerpts from 'Competitive Landscape'

Some of the prominent players operating in the global cataract surgery devices market are

VALUE PROPOSITIONS RELATED TO THE REPORT:

CUSTOMIZATION OPTIONS:

Download PDF Brochure of Cataract Surgery Devices Market Size COVID-19 Impact and Global Analysis with Strategic Developments at: https://growthplusreports.com/inquiry/request-sample/cataract-surgery-devices-market/7846

About Us:

Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

Contact:
Manan Sethi
Director, Market Insights
Email: [email protected]
Phone no: +91 96545 76783
Web: https://growthplusreports.com/ 
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/1671244/Growth_Plus_Reports_Logo.jpg


These press releases may also interest you

at 22:03
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

at 22:00
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

at 21:45
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...

at 21:30
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Will all...

at 20:50
Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results. The revenue was RMB63.5 million, the R&D investment was RMB372 million, the cash and cash equivalent at the end of 2023 was...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company announced that the first patient in China has been dosed in the Phase 1b clinical study of the combination of InnoCare's novel SHP2 (Src Homology 2 domain containing...



News published on and distributed by: